| scholarly article | Q13442814 |
| P50 | author | Brad J Biggerstaff | Q64584555 |
| P2093 | author name string | F Mostashari | |
| D Nash | |||
| G L Campbell | |||
| N Katz | |||
| A J Johnson | |||
| M J Cooper | |||
| M L Bunning | |||
| D A Martin | |||
| E B Hayes | |||
| K A Liljebjelke | |||
| S M Mullin | |||
| A D Fine | |||
| M C Layton | |||
| D A Singer | |||
| P T Kitsutani | |||
| P2860 | cites work | Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay | Q24727662 |
| Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999 | Q27487787 | ||
| West Nile encephalitis epidemic in southeastern Romania | Q29620822 | ||
| The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience | Q33893693 | ||
| A study of the ecology of West Nile virus in Egypt. | Q39088884 | ||
| A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) Cluster Survey design | Q39538451 | ||
| An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. | Q40626312 | ||
| Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. | Q42991248 | ||
| West Nile: a deadly virus? | Q45766554 | ||
| P433 | issue | 9278 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemic | Q44512 |
| West Nile virus | Q158856 | ||
| encephalitis | Q199615 | ||
| West Nile encephalitis | Q18555063 | ||
| P304 | page(s) | 261-4 | |
| P577 | publication date | 2001-07-28 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey | |
| P478 | volume | 358 |
| Q36671970 | A framework for evaluating animals as sentinels for infectious disease surveillance |
| Q25256815 | A human-health risk assessment for West Nile virus and insecticides used in mosquito management |
| Q36607383 | A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice |
| Q40455601 | A patient with leg weakness. |
| Q92375578 | A quantitative comparison of West Nile virus incidence from 2013 to 2018 in Emilia-Romagna, Italy |
| Q28740740 | A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus |
| Q35129151 | A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q37236968 | A review of vaccine approaches for West Nile virus |
| Q33982270 | A seroprevalence study of west nile virus infection in solid organ transplant recipients |
| Q61803642 | Acute and Delayed Deaths after West Nile Virus Infection, Texas, USA, 2002-2012 |
| Q24594634 | Acute flaccid paralysis and West Nile virus infection |
| Q38866173 | An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection |
| Q38590195 | An Update on the Hazards and Risks of Forensic Anthropology, Part II: Field and Laboratory Considerations |
| Q27478055 | Antiviral Peptides Targeting the West Nile Virus Envelope Protein |
| Q35085660 | Antiviral macrophage responses in flavivirus encephalitis |
| Q36353567 | Approach to neuromuscular disorders in the intensive care unit |
| Q38008644 | Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex |
| Q59359717 | Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas |
| Q43047253 | Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination |
| Q40255394 | Arenavirus and West Nile virus in solid organ transplantation. |
| Q36291693 | Arsenite-induced stress granule formation is inhibited by elevated levels of reduced glutathione in West Nile virus-infected cells. |
| Q35872022 | Assessing the risks of West Nile virus-infected mosquitoes from transatlantic aircraft: implications for disease emergence in the United Kingdom |
| Q33988636 | Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study |
| Q40320619 | Asymptomatic infections in man: a Trojan horse for the introduction and spread of mosquito-borne arboviruses in non-endemic areas? |
| Q40549357 | Atypical West Nile virus infection in a child |
| Q27489139 | Behavioral Risks for West Nile Virus Disease, Northern Colorado, 2003 |
| Q45325120 | Biological and phylogenetic characteristics of West African lineages of West Nile virus |
| Q37079789 | Blood group A and D negativity are associated with symptomatic West Nile virus infection |
| Q34108023 | CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission |
| Q38226447 | Challenges of infectious diseases in the USA. |
| Q39477334 | Chapter 10 Viral infections of lower motor neurons. |
| Q37597623 | Characterization of a West Nile virus isolate from a human on the Gulf Coast of Texas |
| Q38261006 | Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis |
| Q98159494 | Clinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital |
| Q39364140 | Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia |
| Q37611824 | Clinical manifestations and outcomes of West Nile virus infection |
| Q94570583 | Comparison of a human neuronal model proteome upon Japanese encephalitis or West Nile Virus infection and potential role of mosquito saliva in neuropathogenesis |
| Q40304517 | Completeness of West Nile virus testing in patients with meningitis and encephalitis during an outbreak in Arizona, USA. |
| Q37664406 | Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012. |
| Q30148695 | Cost effectiveness of a targeted age-based West Nile virus vaccination program |
| Q35793943 | Cost-effectiveness of West Nile virus vaccination |
| Q25256680 | Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States |
| Q40286544 | Current practices and evaluation of screening solid organ donors for West Nile virus |
| Q34788758 | Current trends in West Nile virus vaccine development |
| Q40557867 | Dead bird clusters as an early warning system for West Nile virus activity |
| Q35628958 | Death from the Nile crosses the Atlantic: the West Nile Fever story |
| Q35453070 | Delayed-onset flaccid paralysis related to west Nile virus reactivation following treatment with rituximab: a case report |
| Q34240166 | Demographic and clinical factors associated with persistent symptoms after West Nile virus infection |
| Q38077270 | Descriptive overview of the 2011 epidemic of arboviral disease in horses in Australia. |
| Q40308896 | Detection of West Nile virus genome and specific antibodies in Iranian encephalitis patients. |
| Q39098555 | Determining meteorological drivers of salt marsh mosquito peaks in tropical northern Australia |
| Q38903494 | Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012. |
| Q27486403 | Development of Multiplex PCR-Ligase Detection Reaction Assay for Detection of West Nile Virus |
| Q36322125 | Development of effective therapies against West Nile virus infection |
| Q34160088 | Differential West Nile fever ascertainment in the United States: a multilevel analysis |
| Q28395547 | Discernment between deliberate and natural infectious disease outbreaks |
| Q58853538 | Dogs (Canis familiaris) as Sentinels for Human Infectious Disease and Application to Canadian Populations: A Systematic Review |
| Q38211715 | Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features |
| Q24727663 | Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies |
| Q50532061 | Dynamics of tissue-specific CD8+ T cell responses during West Nile virus infection. |
| Q90186760 | Economic Burden of West Nile Virus Disease, Quebec, Canada, 2012-2013 |
| Q34015866 | Effect of aerial insecticide spraying on West Nile virus disease--north-central Texas, 2012. |
| Q27487482 | Efficacy of Aerial Spraying of Mosquito Adulticide in Reducing Incidence of West Nile Virus, California, 2005 |
| Q35727740 | Emergence of human West Nile Virus infection in Sri Lanka |
| Q34650104 | Emergence of west nile virus lineage 2 in europe: a review on the introduction and spread of a mosquito-borne disease |
| Q35111995 | Emerging Viral Infections of the Nervous System |
| Q35916545 | Emerging and re-emerging infectious diseases: review of general contributing factors and of West Nile virus |
| Q37136479 | Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis |
| Q37119452 | Enhanced West Nile virus surveillance in a dengue-endemic area--Puerto Rico, 2007. |
| Q30250251 | Epidemiological and clinical aspects on West Nile virus, a globally emerging pathogen. |
| Q24603195 | Epidemiology and transmission dynamics of West Nile virus disease |
| Q27490923 | Epidemiology of West Nile virus in the highly epidemic state of North Dakota, 2002-2007 |
| Q28393720 | Epidemiology, geographical distribution, and economic consequences of swine zoonoses: a narrative review |
| Q40285358 | Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. |
| Q40572754 | Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City |
| Q27468900 | Estimating the economic impact of a possible equine and human epidemic of West Nile virus infection in Belgium |
| Q34113896 | Evaluation of prolonged fatigue post-West Nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines |
| Q37211743 | Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages |
| Q36096374 | Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control |
| Q40155194 | Fatal West Nile Virus Encephalitis in a Heart Transplant Recipient |
| Q40242280 | Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010. |
| Q40238557 | Findings of long-term depression up to 8 years post infection from West Nile virus |
| Q28552101 | Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season |
| Q27487086 | Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005 |
| Q27487937 | Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man |
| Q35466057 | Genetic variants and susceptibility to neurological complications following West Nile virus infection |
| Q27473031 | Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic |
| Q38642875 | Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis |
| Q92488121 | HIPK2 is necessary for type I interferon-mediated antiviral immunity |
| Q24261137 | History, Epidemiology, and Clinical Manifestations of Zika: A Systematic Review |
| Q39678081 | Hospital-based enhanced surveillance for West Nile virus neuroinvasive disease |
| Q34026212 | Host genetic risk factors for West Nile virus infection and disease progression |
| Q95819383 | Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections |
| Q34770618 | Identification of class I HLA T cell control epitopes for West Nile virus |
| Q37562139 | Identification of genetic variants associated with susceptibility to West Nile virus neuroinvasive disease |
| Q33769679 | Immune response to the West Nile virus in aged non-human primates |
| Q27489620 | Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys |
| Q36673924 | Immunopathology of flavivirus infections |
| Q33370244 | Impact of climate change and other factors on emerging arbovirus diseases |
| Q30811442 | Important vector-borne infectious diseases among humans in Germany. Epidemiological aspects |
| Q66679185 | In vitro and in silico Models to Study Mosquito-Borne Flavivirus Neuropathogenesis, Prevention, and Treatment |
| Q40037551 | Incidence of West Nile virus infection in the Dallas-Fort Worth metropolitan area during the 2012 epidemic |
| Q33332171 | Incubation Periods of Mosquito-Borne Viral Infections: A Systematic Review |
| Q35943886 | Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors |
| Q77761092 | Infectious disease training: challenges and opportunities |
| Q30400047 | Influenza-like illness in a community surrounding a school-based outbreak of 2009 pandemic influenza A (H1N1) virus-Chicago, Illinois, 2009. |
| Q94524753 | Integrated West Nile Virus Surveillance in Harris County, Texas, 2003 to 2018 |
| Q37111080 | Integrins modulate the infection efficiency of West Nile virus into cells |
| Q24245233 | Intrauterine West Nile virus: ocular and systemic findings |
| Q40346498 | Irrigated agriculture is an important risk factor for West Nile virus disease in the hyperendemic Larimer-Boulder-Weld area of north central Colorado |
| Q40422282 | Juvenile dogs as potential sentinels for West Nile virus surveillance |
| Q27490802 | Key role of T cell defects in age-related vulnerability to West Nile virus |
| Q34557857 | Long-term clinical and neuropsychological outcomes of West Nile virus infection |
| Q35590664 | Long-term neurological outcomes in West Nile virus-infected patients: an observational study |
| Q38852110 | Long-term neuromuscular outcomes of west nile virus infection: A clinical and electromyographic evaluation of patients with a history of infection |
| Q27025556 | Mechanism of West Nile virus neuroinvasion: a critical appraisal |
| Q35590668 | Meteorological conditions associated with increased incidence of West Nile virus disease in the United States, 2004-2012. |
| Q40537444 | MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice |
| Q35883310 | Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium |
| Q38465256 | Modelling geographic variations in West Nile virus. |
| Q35910608 | Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010. |
| Q27478388 | Molecular Typing of West Nile Virus, Dengue, and St. Louis Encephalitis Using Multiplex Sequencing |
| Q35142177 | Molecular detection of West Nile virus RNA. |
| Q52627155 | Morbidity, mortality and long-term sequelae of West Nile virus disease in Québec. |
| Q27469440 | Mosquito surveillance for West Nile virus in southeastern Wisconsin--2002 |
| Q90195807 | Mouse Models as Resources for Studying Infectious Diseases |
| Q34394947 | Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model |
| Q90705326 | Neuroinvasive West Nile Virus Post-Heart Transplantation: A Case Report |
| Q38239006 | Neuroinvasive arboviral disease in the United States: 2003 to 2012. |
| Q35844722 | Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008 |
| Q27488363 | Neurologic Aspects of Infections in International Travelers |
| Q40531877 | Neurological manifestations of West Nile virus infection. |
| Q36063273 | Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada |
| Q57875369 | O vírus do Nilo Ocidental |
| Q28082381 | Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases |
| Q40110506 | Outcomes of West Nile encephalitis patients after 1 year of West Nile encephalitis outbreak in Kerala, India: A follow-up study. |
| Q92306208 | Patients with laboratory evidence of West Nile virus disease without reported fever |
| Q33586206 | Persistence of West Nile virus in the central nervous system and periphery of mice |
| Q24570064 | Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases |
| Q27490502 | Persistent Infection with West Nile Virus Years after Initial Infection |
| Q28119650 | Pokémon Go and Exposure to Mosquito-Borne Diseases: How Not to Catch ‘Em All |
| Q35049023 | Population seroprevalence study after a West Nile virus lineage 2 epidemic, Greece, 2010. |
| Q40490811 | Post-epidemic serosurvey of West Nile fever in Israel |
| Q27487329 | Predictive spatial models for risk of West Nile virus exposure in eastern and western Colorado |
| Q27478202 | Preparation and immunogenic properties of a recombinant West Nile subunit vaccine |
| Q39395766 | Prevalence of IgG antibodies against West Nile virus in blood donors during the 2003 outbreak in Tunisia |
| Q56000903 | Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis |
| Q35226007 | Prognosis of West Nile virus associated acute flaccid paralysis: a case series |
| Q27489893 | Progress on the development of therapeutics against West Nile virus |
| Q35847401 | Protective behavior and West Nile virus risk |
| Q40205083 | Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection |
| Q35726287 | Proximity of residence to bodies of water and risk for west nile virus infection: a case-control study in Houston, Texas. |
| Q35119497 | Rapid GIS-based profiling of West Nile virus transmission: defining environmental factors associated with an urban-suburban outbreak in Northeast Ohio, USA. |
| Q60918413 | Rapidly progressive neurologic decline and morbilliform rash presenting in a patient with lymphoma |
| Q34531170 | Regional differences in the association between land cover and West Nile virus disease incidence in humans in the United States |
| Q27478001 | Relating West Nile virus case fatality rates to demographic and surveillance variables |
| Q36411126 | Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis |
| Q37082586 | Risk factors for West Nile virus infection and disease in populations and individuals |
| Q40479908 | Risk factors for encephalitis and death from West Nile virus infection. |
| Q33876476 | Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. |
| Q56341577 | Sampling considerations for a potential Zika virus urosurvey in New York City |
| Q92488394 | Seasonal temperatures and hydrological conditions improve the prediction of West Nile virus infection rates in Culex mosquitoes and human case counts in New York and Connecticut |
| Q40157177 | Seasonality and survival associated with three outbreak seasons of West Nile virus disease in Oklahoma--2003, 2007, and 2012. |
| Q40398548 | Self-reported protective behaviour against West Nile Virus among pregnant women in Toronto |
| Q40487525 | Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors |
| Q33905035 | Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico |
| Q27482005 | Serological studies of West Nile virus in a liver transplant population |
| Q38980092 | Seroprevalence of West Nile and Usutu viruses in military working horses and dogs, Morocco, 2012: dog as an alternative WNV sentinel species? |
| Q39775950 | Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. |
| Q33571338 | Spatial risk assessments based on vector-borne disease epidemiologic data: importance of scale for West Nile virus disease in Colorado |
| Q35881937 | Spatio-Temporal Identification of Areas Suitable for West Nile Disease in the Mediterranean Basin and Central Europe |
| Q33940173 | Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort |
| Q34086918 | Temporal distribution and spatial pattern of abundance of the Rift Valley fever and West Nile fever vectors in Barkedji, Senegal |
| Q42412541 | The 'One Health' paradigm: Time for infectious diseases clinicians to take note? |
| Q37336735 | The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states |
| Q94522058 | The continued threat of emerging flaviviruses |
| Q36945748 | The continuing spread of West Nile virus in the western hemisphere |
| Q92054805 | The direct healthcare costs attributable to West Nile virus illness in Ontario, Canada: a population-based cohort study using laboratory and health administrative data |
| Q28083311 | The global ecology and epidemiology of West Nile virus |
| Q34231829 | The hazards of blood transfusion in historical perspective |
| Q33989567 | The impact of West Nile virus on the abundance of selected North American birds |
| Q89628762 | The longitudinal health economic impact of viral encephalitis in the United States |
| Q33807075 | The seroprevalence of West Nile Virus in Israel: A nationwide cross sectional study |
| Q37845954 | The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere |
| Q63246637 | Therapeutic Modulation of Virus-Induced Oxidative Stress via the Nrf2-Dependent Antioxidative Pathway |
| Q22305635 | Threat of dengue to blood safety in dengue-endemic countries |
| Q40721930 | Tissue-specific transcription profile of cytokine and chemokine genes associated with flavivirus control and non-lethal neuropathogenesis in rabbits |
| Q29994506 | Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries |
| Q40462028 | Transfusion-associated transmission of West Nile virus, United States 2003 through 2005. |
| Q40550030 | Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 |
| Q43040329 | US in grip of West Nile virus |
| Q27468797 | Use of Testing for West Nile Virus and Other Arboviruses |
| Q40514804 | Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases |
| Q30815812 | Use of wild bird surveillance, human case data and GIS spatial analysis for predicting spatial distributions of West Nile virus in Greece |
| Q98947195 | Using Climate to Explain and Predict West Nile Virus Risk in Nebraska |
| Q37842337 | Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus |
| Q39334302 | Variability in viral pathogenesis: modeling the dynamic of acute and persistent infections |
| Q37680743 | Vector competence of Culex neavei and Culex quinquefasciatus (Diptera: Culicidae) from Senegal for lineages 1, 2, Koutango and a putative new lineage of West Nile virus |
| Q35882094 | Viral encephalitis: neuropsychiatric and neurobehavioral aspects |
| Q24603319 | Virology, pathology, and clinical manifestations of West Nile virus disease |
| Q27488431 | West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function |
| Q34024905 | West Nile Virus Emergence and Persistence in Los Angeles, California, 2003–2008 |
| Q38880775 | West Nile Virus Encephalitis |
| Q40228190 | West Nile Virus Infection in the Immunocompromised Patient |
| Q40047090 | West Nile Virus Outbreak in Houston and Harris County, Texas, USA, 2014. |
| Q35852077 | West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey |
| Q39012426 | West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2015. |
| Q47555260 | West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2016. |
| Q39714513 | West Nile Virus: the buzz on Ottawa residents' awareness, attitudes and practices. |
| Q27469711 | West Nile encephalitis |
| Q35549286 | West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review |
| Q34398570 | West Nile encephalitis: an emerging disease in the United States |
| Q54615771 | West Nile infections in pediatric solid organ transplant recipients. |
| Q64127859 | West Nile virus |
| Q56932479 | West Nile virus |
| Q27482002 | West Nile virus - Mosquitoes no longer just an annoyance! |
| Q27490508 | West Nile virus - Mosquitoes no longer just an annoyance! |
| Q27489548 | West Nile virus Epidemic in Horses, Tuscany Region, Italy |
| Q37262405 | West Nile virus RNA in tissues from donor associated with transmission to organ transplant recipients |
| Q40502172 | West Nile virus among blood donors in the United States, 2003 and 2004. |
| Q34035068 | West Nile virus and its emergence in the United States of America |
| Q38102777 | West Nile virus and kidney disease |
| Q40243125 | West Nile virus and other arboviral diseases--United States, 2012. |
| Q40519491 | West Nile virus blood transfusion-related infection despite nucleic acid testing |
| Q40548182 | West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation |
| Q40535981 | West Nile virus encephalitis in a kidney transplant recipient |
| Q34929428 | West Nile virus encephalitis in the United States |
| Q36008620 | West Nile virus epidemic, northeast Ohio, 2002. |
| Q55396667 | West Nile virus in Canada: ever-changing, but here to stay. |
| Q56909538 | West Nile virus infection |
| Q33776727 | West Nile virus infection among the homeless, Houston, Texas |
| Q27469441 | West Nile virus infection and its neurological manifestations |
| Q40375476 | West Nile virus infection in plasma of blood and plasma donors, United States |
| Q35182679 | West Nile virus infection. What you need to know about this emerging threat |
| Q31041026 | West Nile virus infections projected from blood donor screening data, United States, 2003 |
| Q28260103 | West Nile virus meningoencephalitis |
| Q33610392 | West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes |
| Q34718025 | West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety |
| Q35881069 | West Nile virus outbreak in North American owls, Ontario, 2002 |
| Q27481984 | West Nile virus surveillance and diagnostics: A Canadian perspective |
| Q57216436 | West Nile virus transmission and human infection risk in Veneto (Italy): a modelling analysis |
| Q40518547 | West Nile virus, an emerging arbovirus |
| Q56773518 | West Nile virus, climate change, and circumpolar vulnerability |
| Q51714865 | West Nile virus. |
| Q27473255 | West Nile virus. Primer for family physicians |
| Q36396283 | West Nile virus: a challenge for transplant programs |
| Q35746093 | West Nile virus: a growing concern? |
| Q35625021 | West Nile virus: epidemiology and ecology in North America |
| Q35261421 | West Nile virus: immunity and pathogenesis |
| Q26827766 | West Nile virus: review of the literature |
| Q35494632 | West nile virus (Kunjin subtype) disease in the northern territory of Australia--a case of encephalitis and review of all reported cases |
| Q34425452 | West nile virus and other arboviral diseases - United States, 2013. |
| Q37666773 | West nile virus in the United States - a historical perspective |
| Q30227143 | West nile virus: characteristics of an african virus adapting to the third millennium world. |
| Q27486823 | Why the West in West Nile virus infections? |
| Q22250881 | Zika Virus Outbreak on Yap Island, Federated States of Micronesia |
| Q37473538 | Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses |
| Q36623106 | Zoonotic viral diseases and the frontier of early diagnosis, control and prevention. |
Search more.